参考文献/References:
[1] BEWTRAM B,GANTE C,HILGERS RD.Increase in examinations for cataracts,glaucoma,diabetic retinopathy and age-related macular degeneration:Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices[J].Ophthalmologe,2014,111(8):757-764.
[2] CHAKRAVARTHY U,WONG TY,FLETCHER A,PIAUT E,EVSNS C,ZLATEVA G,et al.Clinical risk factors for agerelatedmacular degeneration:a systematic review and meta-analysis[J].BMC Ophthalmol,2010,10:31.
[3] PATEL JI.Is cataract surgery a risk factor for progression ofmacular degeneration[J]?Curr Opin Ophthalmol,2007,18(1):9-12.
[4] DELCOURT C,COUGNARD A,BONIOL M,DORE JF,DELYFER MN.Lifetime exposure to ambient ultraviolet radiation and the risk for cataract extraction and age-related macular degeneration:the Alienor Study[J].Invest Ophthalmol Vis Sci,2014.55(11):7619-7627.
[5] CUGATI S,MITCHELL P,ROCHTCHINA E,TAN AG,SMITH W,WANG JJ.Cataract surgery and the 10-year incidence of age-related maculopathy[J].Ophthalmology,2006,113(11):2020-2025.
[6] STEVEN S,RYU C,OBER MD.The effects of cataract surgery on patients with wet macular degeneration[J].Am J Ophthalmol,2015,6(6):487-492.
[7] STEINERT RF.白内障手术学[M].北京:人民军医出版社,2012:665.
STEINERT RF.Cataract Surgery[M].Beijing:People’s Military Medical Publishing House,2012:665.
[8] HOOPER CY,LAMOUREUX EL,LIM L,YEOH J,HARPER CA,KEEFFE JE,et al.Cataract surgery in high-risk age-related macular degeneration:a randomized controlled trial[J].Clin Exp Ophthalmol,2009,37(6):570-576.
[9] GRIXTI A,PAPAVASILEIOU E,CORTIS D,KUMAR BV,PRASAD S.Phacoemulsification surgery in eyes with neovascular age-related macular degeneration[J].ISRN Ophthalmol,2014,2014(4):417603.
[10] WANG JJ,FONG CS,ROCHT E,CUGATI S,LORYN TD,KAUSHIK S,et al.Risk of age-related macular degeneration 3 years after cataract surgery:paired eye comparisons[J].Ophthalmology,2012,119(11):2298-2303.
[11] MONESTAM E,LUNDQVIST B.Long-term visual outcome after cataract surgery:comparison of healthy eyes and eyes with age-related macular degeneration[J].J Cataract Refract Surg,2012,38(3):409-414.
[12] 邵玉红,陈肖,赵海岚,吴苗琴.晶状体超声乳化联合人工晶体植入术对合并年龄相关黄斑变性的白内障患者视功能和生存质量的影响[J].中国全科医学,2015,18(17):2038-2042.
SHAO YH,CHEN X,ZHAO HL,WU MQ.Influence of phacoemulsification on the visual function and life quality of patients with cataract complicated with age-related macular degeneration[J].Chin General Pract,2015,18(17):2038-2042.
[13] 邹玉平.白内障基础与临床[M].北京:人民军医出版社,2014:262.
ZOU YP.Cataract:Basic and Clinical[M].Beijing:People’s Military Medical Publishing House,2014:262.
[14] LEE TG,KIM JH,CHANG YS,KIM CG,KIM JW.Factors influencing the exudation recurrence after cataract surgery in patients previously treated with anti-vascular endothelial growth factor for exudative age-related macular degeneration[J].Graefes Arch Clin Experiment Ophthalmol,2014,252(10):1573-1579.
[15] ROSENFELD PJ,SHAPIRO H,EHRLICH JS,WONG P.Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials[J].Am J Ophthalmol,2011,152(5):793-798.
[16] TABANDEH H,CHAUDHRY NA,BOYER DS,KON-JARA VA,FLYNN HW JR.Outcomes of cataract surgery in patientswith neovascularage-related maculardegeneration in the era ofanti-vascularendothelial growth factor therapy[J].J Cataract Refract Surg,2012,38(4):677-682.
[17] 姚燕鸿,张琼,王玲.抗眼底新生血管药物的研究进展[J].国际眼科杂志,2010,10(5):901-904.
YAO YH,ZHANG Q,WANG L.Recent advance of the study on the anti-neovascular drugs for fundus diseases[J].Int Eye Sci,2010,10(5):901-904.
[18] 肖昂,周琼.Aflibercept治疗湿性AMD和黄斑水肿的相关研究现状[J].眼科新进展,2014,34(6):598-600.
XIAO A,ZHOU Q.Related studies on aflibercept for wet AMD and macular edema[J].Rec Adv Ophthalmol,2014,34( 6):598-600.
[19] OKUMA H,MIMURA T,GOTO M,KAMEI Y,YOSHIDA M,KONDO A,et al.Effect of aflibercept in patients with age-related macular degeneration[J].Int J Ophthalmol,2016,36(2):159-169.
[20] LI XX,XU GZ,WANG YS,XU X,LIU XL,TANG SB,et al.Safety and efficacy of conbercept in neovascular age-related macular degeneration[J].Ophthalmology,2014,121:1740-1747.
[21] MAINSTER MA,TURNER PL.Blue-blocking IOLs decrease photoreception without providing significant photoprotection[J].Surv Ophthalmol,2010,55(3):272-289.
[22] NISHI T,SEAK K,OBAYASHI K,OGATA N,MIYATA K,TONE N,et al.The effect of blue-blocking intraocular lenses on circadian biological rhythm:protocol for a randomised controlled trial(CLOCK-IOL colour study)[J].BMJ Open,2015,5(5):1-7.
[23] HENGERER FH,ARTAL P,KOHNEN T,CONRAD-HENGERER I.Initial clinical results of a new telescopic IOL implanted in patients with dry age-related macular degeneration[J].J Refract Surg,2015,31(3):158-162.
[24] BOYER D,FREUND KB,REGILLO C,LEVY MH,GARG S.Long-term(60-month) results for the implantable miniature telescope:efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration[J].Clin Ophthalmol,2015,9:1099-1107.
相似文献/References:
[1]范姜砾 王雨生 张鹏.湿性年龄相关性黄斑变性患者血浆中相关抗氧化酶水平测定[J].眼科新进展,2012,32(5):000.
[2]王毅 李罗翔 李娟 曾庆华.ApoE基因缺失小鼠视网膜及Bruch膜组织形态观察[J].眼科新进展,2013,33(1):000.
[3]徐新荣 仲路 黄冰林 魏源华 周欣 王玲 王富强.年龄相关性黄斑变性血浆蛋白质组学初步研究[J].眼科新进展,2013,33(2):000.
[4]党亚龙 陈彬川 穆雅林 赵满丽 朱豫.i-MP对产生2型脉络膜新生血管的年龄相关性黄斑变性患者视力及黄斑厚度的影响[J].眼科新进展,2013,33(2):000.
[5]王毅 李罗翔 李进辉 李娟 曾庆华.血脂异常ApoE基因缺失小鼠视网膜色素上皮细胞胞浆内黑色素和脂褐素的改变[J].眼科新进展,2013,33(7):000.
[6]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[7]张亚琳 张宁 邹燕红 汤欣 刘熙朴.白内障术后晶状体后囊膜混浊及远期视力下降影响因素分析[J].眼科新进展,2012,32(4):000.
[8]鲁铭 程旭康 罗艳 朱晶.Toric人工晶状体植入矫正白内障合并中高度角膜散光的疗效观察[J].眼科新进展,2013,33(4):000.
[9]陆秉文 吴星伟.光动力疗法治疗年龄相关性黄斑变性的研究进展[J].眼科新进展,2013,33(4):000.
[10]栾兰 姚勇.湿性年龄相关性黄斑变性的治疗进展[J].眼科新进展,2013,33(4):000.